SPSFAM Meeting eBook March 2017

3/9/2017

SPSFAM Cannabis Working Group Members

• Susan Audino, Audino & Associates • Patricia Atkins, SPEX • Roger Brauinger, A2LA • Paula Brown, BCIT • Carolyn Burdette, NIST • Bob Clifford, Shimadzu • Jo Marie Cook, Florida Dept. of Ag • Peter Gibson, GW Pharmaceuticals • Thomas Hartlein, Teledyne Tekmar • Dorota Inerowicz, Indiana State Chemist • Holly Johnson, Alkemist • Erik Konings, Nestlé • Jennifer Donelson, VUV • Kevin George, Eurofins

• Kate Mastovska, Covance • Elizabeth Mudge, BCIT

• Gary Niehaus, Crystal Diagnostics • Masayuki Nishimuram Shimadzu • Melissa Phillips, NIST • Curtis Phinney, Consultant • Klaus Reif, PhytoLab GmbH • Mitzi Rettinger, Millipore Sigma • Kate Rimmer, NIST • Adam Ross, LGC Standards • Travis Ruthenburg, SC Labs • Alicia Stell, CEM • Alan Sutton, GW Pharma • Aniko Solyom, GAAS Analytical • Kathy Stenerson, MilliporeSigma • John Szpylka, Mérieux Nutrisciences

• Julie Kowalski, Phenomenex • Mary Kay Krogull, Eurofins • Julie Kowalski, Restek • Scott Kuzdal, Shimadzu • Robert Lockerman, CEM • Cynthia Ludwig, SAgE

• Jane Weitzel, Consultant • Seth Wong, TEQ Analytical • Josh Wurzer, SC Labs • Hong You, Eurofins

Background

Perspective:  Cannabis Industry Expected to be Worth $50  Billion by 2026 (Bloomberg Markets Report,  September 12, 2016)  Estimated size of the legal US industry (MMJ  and Recreational):  $7.1 Billion in 2016,  increased more than 25% from 2015  89% of Americans support legalization of  medicinal use.  Increased 15% since 2011.  56% Physicians support nationwide legalization  of medicinal cannabis.

2